Please login to the form below

Not currently logged in
Email:
Password:

Porter Novelli appoints Sally Ward as MD

PR agency Porter Novelli has appointed Sally Ward as partner and managing director of its operations in the UK

PR agency Porter Novelli has appointed Sally Ward as partner and managing director of its operations in the UK. Ward replaces Jean Wyllie, who announced her departure from the agency late last year.

Ward was previously founder and director of Plum Consulting, an executive search, talent management and senior-level coaching and mentoring firm. Prior to this she spent five years with Weber Shandwick UK; and before then seven years with Porter Novelli (known then as Countrywide Porter Novelli) as a portfolio director and later as the agency's UK development director.

 

Sally Ward
Sally Ward

 

"We are delighted to welcome Sally back to the agency," said Gary Stockman, CEO, Porter Novelli. "She is an extremely well-respected leader in the industry with a 20-year track record of growing business both domestically and across borders. Her emphasis and personal commitment to attracting and developing talent will be especially valuable."

Ward said: "Taking on this role was a challenge that I couldn't resist. Porter Novelli remains a strong brand synonymous with quality work, and I look forward to helping to grow its position in the marketplace. Addressing that will be exciting, as will the opportunity to build an industry-leading team."

In addition to her roles as UK MD and partner, Ward will join Porter Novelli's executive committee.
 

28th January 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....